Search Results - "Larson, Pamela S"

Allele Imbalance, or Loss of Heterozygosity, in Normal Breast Epithelium of Sporadic Breast Cancer Cases and BRCA1 Gene Mutation Carriers Is Increased Compared With Reduction Mammoplasty Tissues by LARSON, Pamela S, SCHLECHTER, Benjamin L, DE LAS MORENAS, Antonio, GARBER, Judy E, CUPPLES, L. Adrienne, ROSENBERG, Carol L

“…Normal-appearing breast epithelium can contain genetic abnormalities, including allele imbalance (AI), also referred to as loss of heterozygosity. Whether…”
Get full text

Quantitative DNA Fingerprinting May Distinguish New Primary Breast Cancer From Disease Recurrence by SCHLECHTER, Benjamin L, QIONG YANG, LARSON, Pamela S, GOLUBEVA, Arina, BLANCHARD, Rita A, DE LAS MORENAS, Antonio, ROSENBERG, Carol L

“…Approximately 10% of women with breast cancer develop a second breast tumor, either a new primary or a recurrence. Differentiating between these entities using…”
Get full text

Loss of Heterozygosity or Allele Imbalance in Histologically Normal Breast Epithelium Is Distinct from Loss of Heterozygosity or Allele Imbalance in Co-Existing Carcinomas by Larson, Pamela S., de las Morenas, Antonio, Bennett, Sheila R., Cupples, L. Adrienne, Rosenberg, Carol L.

“…To better understand early steps in human breast carcinogenesis, we examined allele imbalance or loss of heterozygosity (LOH), in co-existing normal-appearing…”
Get full text

In utero exposure to diethylstilbestrol (DES) does not increase genomic instability in normal or neoplastic breast epithelium by Larson, Pamela S., Ungarelli, Rosemarie A., de las Morenas, Antonio, Cupples, L. Adrienne, Rowlings, Kathleen, Palmer, Julie R., Rosenberg, Carol L.

“…BACKGROUND. In 1992, the National Cancer Institute (NCI) established the Continuation of Follow‐Up of DES‐Exposed Cohorts to study the long‐term health effects…”
Get full text

Genetically abnormal clones in histologically normal breast tissue by Larson, PS, de las Morenas, A, Cupples, LA, Huang, K, Rosenberg, CL

“…Breast cancer is believed to develop as multiple genetic abnormalities accumulate, each conferring some growth advantage, but the timing and nature of the…”
Get full text

CDKN1C/p57kip2 is a candidate tumor suppressor gene in human breast cancer by Larson, Pamela S, Schlechter, Benjamin L, King, Chia-Lin, Yang, Qiong, Glass, Chelsea N, Mack, Charline, Pistey, Robert, de Las Morenas, Antonio, Rosenberg, Carol L

“…CDKN1C (also known as p57KIP2) is a cyclin-dependent kinase inhibitor previously implicated in several types of human cancer. Its family members…”
Get full text

Loss of heterozygosity in serial plasma DNA samples during follow‐up of women with breast cancer by Wang, Qiu, Larson, Pamela S., Schlechter, Benjamin L., Zahid, Naila, Finnemore, Erin, de las Morenas, Antonio, Blanchard, Rita A., Rosenberg, Carol L.

“…We evaluated the potential utility of occult circulating tumor DNA as a molecular marker of disease in subjects previously diagnosed with breast cancer. Using…”
Get full text

Microsatellite alterations indicating monoclonality in atypical hyperplasias associated with breast cancer by Rosenberg, Carol L, Larson, Pamela S, Romo, John D, De Las Morenas, Antonio, Faller, Douglas V

“…One model of breast tumorigenesis postulates a sequential evolution from normal to proliferative epithelium and eventually to neoplasia, but genetic data to…”
Get full text

CDKN1C/p57kip2is a candidate tumor suppressor gene in human breast cancer by Larson, Pamela S, Schlechter, Benjamin L, King, Chia-Lin, Yang, Qiong, Glass, Chelsea N, Mack, Charline, Pistey, Robert, de las Morenas, Antonio, Rosenberg, Carol L

“…Abstract Background CDKN1C (also known as p57 KIP2 ) is a cyclin-dependent kinase inhibitor previously implicated in several types of human cancer. Its family…”
Get full text

CDKN1C /p57.sup.kip2 .sup.is a candidate tumor suppressor gene in human breast cancer by Larson, Pamela S, Schlechter, Benjamin L, King, Chia-Lin, Yang, Qiong, Glass, Chelsea N, Mack, Charline, Pistey, Robert, de las Morenas, Antonio, Rosenberg, Carol L

Get full text

DNA alterations in tumor scrapesvs. biopsies of squamous-cell carcinomas of the head and neck by Rosenberg, Carol L., Finnemore, Erin M., Larson, Pamela S., Nogueira, Christine P., Delaney, Thomas L.

Get full text

CDKN1C/p57 super(kip2 )is a candidate tumor suppressor gene in human breast cancer by Larson, Pamela S, Schlechter, Benjamin L, King, Chia-Lin, Yang, Qiong, Glass, Chelsea N, Mack, Charline, Pistey, Robert, de las Morenas, Antonio, Rosenberg, Carol L

“…Background CDKN1C (also known as p57 super(KIP2)) is a cyclin-dependent kinase inhibitor previously implicated in several types of human cancer. Its family…”
Get full text

Loss of heterozygosity at 11q23 in squamous cell carcinoma of the head and neck is associated with recurrent disease by LAZAR, A. D, WINTER, M. R, NOGUEIRA, C. P, LARSON, P. S, FINNEMORE, E. M, DOLAN, R. W, FULEIHAN, N, CHAKRAVARTI, A, ZIETMAN, A, ROSENBERG, C. L

“…Loss of heterozygosity (LOH) at chromosome 11q23 has been found in a variety of epithelial human neoplasms, suggesting that this region contains a tumor…”
Get full text

Detection of monoclonal microsatellite alterations in atypical breast hyperplasia by Rosenberg, C L, de las Morenas, A, Huang, K, Cupples, L A, Faller, D V, Larson, P S

“…Atypical hyperplastic (AH) breast lesions are currently classified and treated as benign proliferative disorders, but their presence is associated with a four-…”
Get full text

DNA alterations in tumor scrapes vs. biopsies of squamous‐cell carcinomas of the head and neck by Rosenberg, Carol L., Finnemore, Erin M., Larson, Pamela S., Nogueira, Christine P., Delaney, Thomas L.

“…Genetic abnormalities in SCCHNs are frequent and may be useful for screening, follow‐up and prognosis. A biopsy or resection generally is utilized to identify…”
Get full text

Lack of correlation between morphometric analysis and presence of microsatellite alterations in proliferative ductal lesions of the breast by Zucca, M P, Larson, P S, Rosenberg, C L, de las Morenas, A

“…To apply morphometric studies using an image analyzer to a previously reported group of proliferative duct lesions and to compare results to see if there was a…”
Get more information